A citation-based method for searching scientific literature

Disha Rao, Fabienne Verburg, Kathrin Renner, Daniel S Peeper, Ruben Lacroix, Christian U Blank. Cancer Immunol Immunother 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ATP citrate lyase: A central metabolic enzyme in cancer.
Philippe Icard, Zherui Wu, Ludovic Fournel, Antoine Coquerel, Hubert Lincet, Marco Alifano. Cancer Lett 2020
30
50

Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer.
Nikos Koundouros, George Poulogiannis. Front Oncol 2018
121
50

Digital signaling and hysteresis characterize ras activation in lymphoid cells.
Jayajit Das, Mary Ho, Julie Zikherman, Christopher Govern, Ming Yang, Arthur Weiss, Arup K Chakraborty, Jeroen P Roose. Cell 2009
273
50

Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.
Surbhi Gupta, Antoine R Ramjaun, Paula Haiko, Yihua Wang, Patricia H Warne, Barbara Nicke, Emma Nye, Gordon Stamp, Kari Alitalo, Julian Downward. Cell 2007
428
50

The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements.
Claudio Procaccini, Fortunata Carbone, Dario Di Silvestre, Francesca Brambilla, Veronica De Rosa, Mario Galgani, Deriggio Faicchia, Gianni Marone, Donatella Tramontano, Marco Corona,[...]. Immunity 2016
136
50

Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming.
Young Chan Chae, Valentina Vaira, M Cecilia Caino, Hsin-Yao Tang, Jae Ho Seo, Andrew V Kossenkov, Luisa Ottobrini, Cristina Martelli, Giovanni Lucignani, Irene Bertolini,[...]. Cancer Cell 2016
89
50

6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27.
A Yalcin, B F Clem, Y Imbert-Fernandez, S C Ozcan, S Peker, J O'Neal, A C Klarer, A L Clem, S Telang, J Chesney. Cell Death Dis 2014
102
50

Mitochondrial oxidative phosphorylation is regulated by fructose 1,6-bisphosphate. A possible role in Crabtree effect induction?
Rodrigo Díaz-Ruiz, Nicole Avéret, Daniela Araiza, Benoît Pinson, Salvador Uribe-Carvajal, Anne Devin, Michel Rigoulet. J Biol Chem 2008
91
50

PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.
Helga Simon-Molas, Claudia Arnedo-Pac, Pere Fontova, Anna Vidal-Alabró, Esther Castaño, Ana Rodríguez-García, Àurea Navarro-Sabaté, Núria Lloberas, Anna Manzano, Ramon Bartrons. Mol Cell Biochem 2018
14
50

Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity.
Ke Xu, Na Yin, Min Peng, Efstathios G Stamatiades, Amy Shyu, Peng Li, Xian Zhang, Mytrang H Do, Zhaoquan Wang, Kristelle J Capistrano,[...]. Science 2021
24
50

Fructose-1,6-bisphosphate couples glycolytic flux to activation of Ras.
Ken Peeters, Frederik Van Leemputte, Baptiste Fischer, Beatriz M Bonini, Hector Quezada, Maksym Tsytlonok, Dorien Haesen, Ward Vanthienen, Nuno Bernardes, Carmen Bravo Gonzalez-Blas,[...]. Nat Commun 2017
72
50

Serine Is an Essential Metabolite for Effector T Cell Expansion.
Eric H Ma, Glenn Bantug, Takla Griss, Stephanie Condotta, Radia M Johnson, Bozena Samborska, Nello Mainolfi, Vipin Suri, Hannah Guak, Maria L Balmer,[...]. Cell Metab 2017
214
50

Fructose 2,6-bisphosphate metabolism in Ehrlich ascites tumour cells.
K Nissler, H Petermann, I Wenz, D Brox. J Cancer Res Clin Oncol 1995
24
50

Metabolism as a guiding force for immunity.
Jonathan Jung, Hu Zeng, Tiffany Horng. Nat Cell Biol 2019
81
50

CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness.
Tomasz Ahrends, Aldo Spanjaard, Bas Pilzecker, Nikolina Bąbała, Astrid Bovens, Yanling Xiao, Heinz Jacobs, Jannie Borst. Immunity 2017
133
50

Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity.
Hirotake Tsukamoto, Koji Fujieda, Satoru Senju, Tokunori Ikeda, Hiroyuki Oshiumi, Yasuharu Nishimura. Cancer Sci 2018
52
50

[Traumatology and diagnosis of scaphoid fracture].
K Schunk, W Weber, H Strunk, H Regentrop, R Thelen, H Schild. Radiologe 1989
131
50

Quantification of DNA Damage by Real-Time qPCR.
Wei Wang, Katja Scheffler, Ying Esbensen, Lars Eide. Methods Mol Biol 2016
14
50

Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis.
Kenichi Shimada, Timothy R Crother, Justin Karlin, Jargalsaikhan Dagvadorj, Norika Chiba, Shuang Chen, V Krishnan Ramanujan, Andrea J Wolf, Laurent Vergnes, David M Ojcius,[...]. Immunity 2012
50

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.
Hirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, Mamoru Ito, Akitaka Makiyama, Keita Uchino, Hozumi Shimokawa, Shingo Tamura, Taito Esaki, Kenji Mitsugi,[...]. Br J Cancer 2020
18
50

HaploGrep 2: mitochondrial haplogroup classification in the era of high-throughput sequencing.
Hansi Weissensteiner, Dominic Pacher, Anita Kloss-Brandstätter, Lukas Forer, Günther Specht, Hans-Jürgen Bandelt, Florian Kronenberg, Antonio Salas, Sebastian Schönherr. Nucleic Acids Res 2016
317
50

HaploGrep: a fast and reliable algorithm for automatic classification of mitochondrial DNA haplogroups.
Anita Kloss-Brandstätter, Dominic Pacher, Sebastian Schönherr, Hansi Weissensteiner, Robert Binna, Günther Specht, Florian Kronenberg. Hum Mutat 2011
303
50

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.
Nicole E Scharping, Ashley V Menk, Rebecca S Moreci, Ryan D Whetstone, Rebekah E Dadey, Simon C Watkins, Robert L Ferris, Greg M Delgoffe. Immunity 2016
259
50



Classification of European mtDNAs from an analysis of three European populations.
A Torroni, K Huoponen, P Francalacci, M Petrozzi, L Morelli, R Scozzari, D Obinu, M L Savontaus, D C Wallace. Genetics 1996
600
50

Mitochondrial DNA in innate immune responses and inflammatory pathology.
A Phillip West, Gerald S Shadel. Nat Rev Immunol 2017
334
50

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.
Chih-Hao Chang, Jing Qiu, David O'Sullivan, Michael D Buck, Takuro Noguchi, Jonathan D Curtis, Qiongyu Chen, Mariel Gindin, Matthew M Gubin, Gerritje J W van der Windt,[...]. Cell 2015
50

Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer.
Paula A Bousquet, Sebastian Meltzer, Linda Sønstevold, Ying Esbensen, Svein Dueland, Kjersti Flatmark, Beathe Sitter, Tone Frost Bathen, Therese Seierstad, Kathrine Røe Redalen,[...]. Transl Oncol 2019
8
50

Matrilineal diversity and population history of Norwegians.
Dana Kristjansson, Jon Bohlin, Astanand Jugessur, Theodore G Schurr. Am J Phys Anthropol 2021
1
100

Circulating mitochondrial DAMPs cause inflammatory responses to injury.
Qin Zhang, Mustafa Raoof, Yu Chen, Yuka Sumi, Tolga Sursal, Wolfgang Junger, Karim Brohi, Kiyoshi Itagaki, Carl J Hauser. Nature 2010
50

Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA.
R M Andrews, I Kubacka, P F Chinnery, R N Lightowlers, D M Turnbull, N Howell. Nat Genet 1999
50

Effects of purifying and adaptive selection on regional variation in human mtDNA.
Eduardo Ruiz-Pesini, Dan Mishmar, Martin Brandon, Vincent Procaccio, Douglas C Wallace. Science 2004
547
50

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer.
Maria Thomsen, Christian Kersten, Halfdan Sorbye, Eva Skovlund, Bengt Glimelius, Per Pfeiffer, Julia S Johansen, Elin H Kure, Tone Ikdahl, Kjell Magne Tveit,[...]. Oncotarget 2016
39
50

Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy.
Hidemitsu Kitamura, Yosuke Ohno, Yujiro Toyoshima, Junya Ohtake, Shigenori Homma, Hideki Kawamura, Norihiko Takahashi, Akinobu Taketomi. Cancer Sci 2017
103
50

CD4+ T cell help in cancer immunology and immunotherapy.
Jannie Borst, Tomasz Ahrends, Nikolina Bąbała, Cornelis J M Melief, Wolfgang Kastenmüller. Nat Rev Immunol 2018
372
50

Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.
Kanstantsin V Katlinski, Jun Gui, Yuliya V Katlinskaya, Angelíca Ortiz, Riddhita Chakraborty, Sabyasachi Bhattacharya, Christopher J Carbone, Daniel P Beiting, Melanie A Girondo, Amy R Peck,[...]. Cancer Cell 2017
109
50

The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.
Javier Ros, Iosune Baraibar, Giulia Martini, Francesc Salvà, Nadia Saoudi, José Luis Cuadra-Urteaga, Rodrigo Dienstmann, Josep Tabernero, Elena Élez. Curr Treat Options Oncol 2021
1
100


Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy.
Jannie Borst, Julia Busselaar, Douwe M T Bosma, Ferry Ossendorp. Eur J Immunol 2021
4
50


The Ensembl Variant Effect Predictor.
William McLaren, Laurent Gil, Sarah E Hunt, Harpreet Singh Riat, Graham R S Ritchie, Anja Thormann, Paul Flicek, Fiona Cunningham. Genome Biol 2016
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Disuniting uniformity: a pied cladistic canvas of mtDNA haplogroup H in Eurasia.
Eva-Liis Loogväli, Urmas Roostalu, Boris A Malyarchuk, Miroslava V Derenko, Toomas Kivisild, Ene Metspalu, Kristiina Tambets, Maere Reidla, Helle-Viivi Tolk, Jüri Parik,[...]. Mol Biol Evol 2004
131
50

Extreme heterogeneity of human mitochondrial DNA from organelles to populations.
James B Stewart, Patrick F Chinnery. Nat Rev Genet 2021
23
50

Peripheral T cell expansion predicts tumour infiltration and clinical response.
Thomas D Wu, Shravan Madireddi, Patricia E de Almeida, Romain Banchereau, Ying-Jiun J Chen, Avantika S Chitre, Eugene Y Chiang, Hina Iftikhar, William E O'Gorman, Amelia Au-Yeung,[...]. Nature 2020
146
50

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Jean-François Bosset, Gilles Calais, Laurent Mineur, Philippe Maingon, Suzana Stojanovic-Rundic, René-Jean Bensadoun, Etienne Bardet, Alexander Beny, Jean-Claude Ollier, Michel Bolla,[...]. Lancet Oncol 2014
401
50

Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.
Rodrigo Dienstmann, Louis Vermeulen, Justin Guinney, Scott Kopetz, Sabine Tejpar, Josep Tabernero. Nat Rev Cancer 2017
341
50

Signal interaction between the tumour and inflammatory cells in patients with gastrointestinal cancer: Implications for treatment.
Kathryn A F Pennel, James H Park, Donald C McMillan, Antonia K Roseweir, Joanne Edwards. Cell Signal 2019
9
50

Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Claus Rödel, Ullrich Graeven, Rainer Fietkau, Werner Hohenberger, Torsten Hothorn, Dirk Arnold, Ralf-Dieter Hofheinz, Michael Ghadimi, Hendrik A Wolff, Marga Lang-Welzenbach,[...]. Lancet Oncol 2015
348
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.